Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities

被引:280
|
作者
Davis, Ryan J. [1 ,2 ,3 ]
Welcker, Markus [1 ,2 ]
Clurman, Bruce E. [1 ,2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA
[3] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA
基金
美国国家科学基金会;
关键词
F-BOX PROTEIN; ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL DIFFERENTIATION; FBXW7; BETA-FORM; CYCLIN-E; C-MYC; DEPENDENT DEGRADATION; PROMOTER HYPERMETHYLATION; MULTISITE PHOSPHORYLATION; SUBSTRATE RECOGNITION;
D O I
10.1016/j.ccell.2014.09.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor suppressors with widespread impact on carcinogenesis control broad spectra of oncogenic pathways. Protein degradation is an emerging mechanism by which tumor suppressors regulate a diversity of pathways and is exemplified by the SCFFbw7 ubiquitin ligase. Rapidly accumulating data indicate that SCFFbw7 regulates a network of crucial oncoproteins. Importantly, the FBXW7 gene, which encodes Fbw7, is one of the most frequently mutated genes in human cancers. These studies are yielding important new insights into tumorigenesis and may soon enable therapies targeting the Fbw7 pathway. Here, we focus on the mechanisms and consequences of Fbw7 deregulation in cancers and discuss possible therapeutic approaches.
引用
收藏
页码:455 / 464
页数:10
相关论文
共 50 条
  • [1] Role of the ubiquitin ligase Fbw7 in cancer progression
    Cheng, Yabin
    Li, Gang
    [J]. CANCER AND METASTASIS REVIEWS, 2012, 31 (1-2) : 75 - 87
  • [2] Role of the ubiquitin ligase Fbw7 in cancer progression
    Yabin Cheng
    Gang Li
    [J]. Cancer and Metastasis Reviews, 2012, 31 : 75 - 87
  • [3] The Fbw7 tumor suppressor: Genetic and biochemical approaches to study a dimeric ubiquitin ligase
    Larimore, Elizabeth A.
    Welcker, Markus
    Clurman, Bruce E.
    [J]. CANCER RESEARCH, 2012, 72
  • [4] Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor
    Fuchs, SY
    [J]. CANCER BIOLOGY & THERAPY, 2005, 4 (05) : 506 - 508
  • [5] Metabolic reprogramming caused by mutations of the Fbw7 ubiquitin ligase in colorectal cancer
    Davis, Ryan J.
    Gonen, Mehmet
    Hockenbery, David
    Margolin, Adam
    Clurman, Bruce E.
    [J]. CANCER RESEARCH, 2017, 77
  • [6] Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7
    Rocher-Ros, V.
    Marco, S.
    Mao, J-H
    Gines, S.
    Metzger, D.
    Chambon, P.
    Balmain, A.
    Saura, C. A.
    [J]. ONCOGENE, 2010, 29 (20) : 2950 - 2961
  • [7] Nucleolar Targeting of the Fbw7 Ubiquitin Ligase by a Pseudosubstrate and Glycogen Synthase Kinase 3
    Welcker, Markus
    Larimore, Elizabeth A.
    Frappier, Lori
    Clurman, Bruce E.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (06) : 1214 - 1224
  • [8] Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7
    V Rocher-Ros
    S Marco
    J-H Mao
    S Gines
    D Metzger
    P Chambon
    A Balmain
    C A Saura
    [J]. Oncogene, 2010, 29 : 2950 - 2961
  • [9] Ubiquitin ligase component fbw7 regulates the quiescence of hematopoietic stem cells.
    Matsuoka, Sahoko
    Oike, Yuichi
    Onoyama, Ichiro
    Takubo, Keiyo
    Ito, Keisuke
    Arai, Fumio
    Ikeda, Yasuo
    Nakayama, Keiko
    Nakayama, Keiichi
    Suda, Toshio
    [J]. BLOOD, 2006, 108 (11) : 28A - 28A
  • [10] FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
    Markus Welcker
    Bruce E. Clurman
    [J]. Nature Reviews Cancer, 2008, 8 : 83 - 93